UNBELIEVABLE: Nvmdf | History Defined

Novamind To Offer Psychedelic-Assisted Group Therapy

Novamind Inc. (OTCQB:NVMDF) has announced that it will offer a model of psychedelic-assisted group therapy. Under the name Groups by Novamind, the therapy model will offer psychedelic integration and in-person group psychedelic-assisted psychotherapy for four to ten individuals delivered as drop-in sessions or multi-week curricula. According to the company, the…

Benzinga · Mar 24, 2022

Novamind Stock Slightly Up On Grants Restricted Share Units

Novamind Inc. (OTCQB:NVMDF)(CSE:NM)(FSE:HN2) a mental health company specialized in psychedelic medicine, has granted an aggregate of 325,000 restricted share units effective March 11, 2022, to certain executives and employees of the company pursuant to its restricted share unit plan. The RSUs will vest in 25% intervals, every 6 months from…

Benzinga · Mar 11, 2022

Novamind To Conduct Phase II Psilocybin Trial For Major Depressive Disorder

Novamind Inc. (OTCQB:NVMDF) (CSE:NM)(FSE:HN2) will conduct a phase II clinical trial investigating psilocybin for major depressive disorder sponsored by the Usona Institute. The company completed first patient randomization at its Draper, Utah research site.

Benzinga · Mar 9, 2022